Table 4. Multivariate analysis of potential risk factors for mortality in patients with PUD (with and without HP therapy).
| Variable | Multivariate analysis | |||
|---|---|---|---|---|
| HR | 95% CI | P value | ||
| Group | ||||
| Patients without HP therapy | 1 | |||
| Patients with HP therapy (≤ 365 days) | 0.86 | 0.67 | 1.11 | 0.2428 |
| Age | 1.08 | 1.07 | 1.09 | <.0001 |
| Gender (male is reference) | 0.58 | 0.44 | 0.77 | 0.0001 |
| Charlson comorbidity | ||||
| Dementia | 2.05 | 0.50 | 8.34 | 0.3178 |
| Pulmonary disease | 1.01 | 0.59 | 1.73 | 0.9610 |
| Connective tissue disorder | 1.19 | 0.17 | 8.49 | 0.8650 |
| Peptic ulcer | 0.69 | 0.48 | 0.99 | 0.0424 |
| Liver disease | 1.07 | 0.53 | 2.19 | 0.8474 |
| Paraplegia | 0 | -- | -- | -- |
| Renal disease | 1.78 | 0.44 | 7.29 | 0.4206 |
| Comorbidity | ||||
| Hypertension | 1.04 | 0.73 | 1.48 | 0.8266 |
| Hyperlipidemia | 0.70 | 0.32 | 1.49 | 0.3518 |
Abbreviations: HP: Helicobacter pylori; CI: confidence interval